REINFORCING the clinical utility of an antibacterial envelope to prevent infection following a cardiac implantable electronic device implant procedure
- PMID: 37672647
- PMCID: PMC10637297
- DOI: 10.1093/europace/euad260
REINFORCING the clinical utility of an antibacterial envelope to prevent infection following a cardiac implantable electronic device implant procedure
Conflict of interest statement
Conflict of interest: S.M. is a consultant to Medtronic.
Comment on
-
REducing INFectiOns thRough Cardiac device Envelope: insight from real world data. The REINFORCE project.Europace. 2023 Nov 2;25(11):euad224. doi: 10.1093/europace/euad224. Europace. 2023. PMID: 37490930 Free PMC article.
References
-
- Palmeri NO, Kramer DB, Karchmer AW, Zimetbaum PJ. A review of cardiac electronic device infections for the practicing electrophysiologist. J Am Coll Cardiol 2021;7:811–24. - PubMed
-
- Bloom HL, Constantin L, Dan D, De Lurgio DB, El-Chami M, Ganz LIet al. . Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol 2011;34:133–42. - PubMed
-
- Henrikson CA, Sohail MR, Acosta H, Johnson EE, Rosenthal L, Pachulski Ret al. . Antibacterial envelope is associated with low infection rates after implantable cardioverter-defibrillator and cardiac resynchronization therapy device replacement: results of the Citadel and Centurion studies. J Am Coll Cardiol 2017;3:1158–67. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
